論文

査読有り
2014年5月

Recombinant fusion protein of cholera toxin B subunit with YVAD secreted by Lactobacillus casei inhibits lipopolysaccharide-induced caspase-1 activation and subsequent IL-1 beta secretion in Caco-2 cells

BMC BIOTECHNOLOGY
  • Yukihiro Hiramatsu
  • Masatatsu Yamamoto
  • Tomomitsu Satho
  • Keiichi Irie
  • Akiko Kai
  • Saori Uyeda
  • Yuki Fukumitsu
  • Akihisa Toda
  • Takeshi Miyata
  • Fumio Miake
  • Takeshi Arakawa
  • Nobuhiro Kashige
  • 全て表示

14
開始ページ
38
終了ページ
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1186/1472-6750-14-38
出版者・発行元
BIOMED CENTRAL LTD

Background: Lactobacillus species are used as bacterial vectors to deliver functional peptides to the intestine because they are delivered live to the intestine, colonize the mucosal surface, and continue to produce the desired protein. Previously, we generated a recombinant Lactobacillus casei secreting the cholera toxin B subunit (CTB), which can translocate into intestinal epithelial cells (IECs) through GM1 ganglioside. Recombinant fusion proteins of CTB with functional peptides have been used as carriers for the delivery of these peptides to IECs because of the high cell permeation capacity of recombinant CTB (rCTB). However, there have been no reports of rCTB fused with peptides expressed or secreted by Lactobacillus species. In this study, we constructed L. casei secreting a recombinant fusion protein of CTB with YVAD (rCTB-YVAD). YVAD is a tetrapeptide (tyrosine-valine-alanine-aspartic acid) that specifically inhibits caspase-1, which catalyzes the production of interleukin (IL)-1 beta, an inflammatory cytokine, from its inactive precursor. Here, we examined whether rCTB-YVAD secreted by L. casei binds to GM1 ganglioside and inhibits caspase-1 activation in Caco-2 cells used as a model of IECs.
Results: We constructed the rCTB-YVAD secretion vector pSCTB-YVAD by modifying the rCTB secretion vector pSCTB. L. casei secreting rCTB-YVAD was generated by transformation with pSCTB-YVAD. Both the culture supernatant of pSCTB-YVAD-transformed L. casei and purified rCTB-YVAD bound to GM1 ganglioside, as did the culture supernatant of pSCTB-transformed L. casei and purified rCTB. Interestingly, although both purified rCTB-YVAD and rCTB translocated into Caco-2 cells, regardless of lipopolysaccharide (LPS), only purified rCTB-YVAD but not rCTB inhibited LPS-induced caspase-1 activation and subsequent IL-1 beta secretion in Caco-2 cells, without affecting cell viability.
Conclusions: The rCTB protein fused to a functional peptide secreted by L. casei can bind to GM1 ganglioside, like rCTB, and recombinant YVAD secreted by L. casei may exert anti-inflammatory effects in the intestine. Therefore, rCTB secreted by L. casei has potential utility as a vector for the delivery of YVAD to IECs.

リンク情報
DOI
https://doi.org/10.1186/1472-6750-14-38
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/24884459
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000336231600001&DestApp=WOS_CPL
ID情報
  • DOI : 10.1186/1472-6750-14-38
  • ISSN : 1472-6750
  • PubMed ID : 24884459
  • Web of Science ID : WOS:000336231600001

エクスポート
BibTeX RIS